Position in GPCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,030,538
+$472,366 QoQ
Shares Held
242,790
-6.8% QoQ
Ownership
0.340%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 190 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Jun 30, 2026CallValue
$7,782,150
CallShares
145,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. GPCR ranks #143 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in GPCR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,030,538 | 242,790 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $7,782,150 | 145,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $8,362,700 | 173,500 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $12,558,172 | 260,543 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,602,290 | 224,332 | Shares | Defined | 2026-03-25 | |
| 2025-12-31 | $12,066,925 | 173,500 | Call | Defined | 2026-03-25 | |
| 2025-09-30 | $14,123,088 | 504,396 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,566,408 | 220,174 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,615,969 | 324,435 | Shares | Defined | 2025-06-27 | |
| 2025-03-31 | $605,850 | 35,000 | Call | Defined | 2025-06-27 | |
| 2024-12-31 | $15,807,298 | 582,865 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $31,284,572 | 712,795 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $583,737 | 13,300 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $26,796,395 | 682,363 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,230,039 | 448,671 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,434,478 | 427,735 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,601,651 | 71,433 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||